![Glynn Wilson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Glynn Wilson
Direktor/Vorstandsmitglied bei
CADRENAL THERAPEUTICS, INC.
Vermögen: 571 532 $ am 31.05.2026
Profil
Dr. Glynn Wilson is a Chief Executive Officer & Director at Caring Brands, Inc. and an Independent Director at Cadrenal Therapeutics, Inc. He is on the Board of Directors at Caring Brands, Inc. and Cadrenal Therapeutics, Inc. Dr. Wilson was previously employed as a Chief Scientific Officer by Bonk, Inc., a Chief Scientific Officer by Auriga Laboratories, Inc. /Old/, a Chairman by TapImmune, Inc., a Chairman by Tapimmune, Inc., a President & Chief Executive Officer by PharmaSpec Corp., a Vice President-Research & Development by PlasmaTech Biopharmaceuticals, Inc., a Chief Scientific Officer by Tacora Corp, a Head-Worldwide Drug Delivery by Smithkline Beecham Plc, a Research Head-Cell & Molecular Biology by Ciba-Geigy Pharmaceuticals, and a President & Chief Executive Officer by The GW Group.
He received his doctorate degree from The Rockefeller University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
5.5% | 27.03.2026 | 500’000 ( 5.5% ) | 555 000 $ | 31.05.2026 |
| 28.07.2025 | 3’333 ( 0.12% ) | 16 532 $ | 31.05.2026 |
Aktive Positionen von Glynn Wilson
| Unternehmen | Position | Beginn |
|---|---|---|
| CADRENAL THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 19.01.2023 |
Ehemalige bekannte Positionen von Glynn Wilson
| Unternehmen | Position | Ende |
|---|---|---|
| MARKER THERAPEUTICS, INC. | Vorstandsvorsitzender | 25.09.2017 |
Tapimmune, Inc. | Vorstandsvorsitzender | 01.09.2017 |
Auriga Laboratories, Inc. /Old/
 Auriga Laboratories, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Researches and develops pharmaceutical products | Präsident | 13.03.2006 |
PharmaSpec Corp. | Präsident | 01.01.2000 |
| ABEONA THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1998 |
Ausbildung von Glynn Wilson
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
59
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Abeona Therapeutics, Inc.
 Abeona Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cell and gene therapies for life-threatening rare genetic diseases | Health Technology |
Smithkline Beecham Plc
 Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Marker Therapeutics, Inc.
 Marker Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes cell based immune therapeutics and vaccines for cancer treatment | Health Technology |
Auriga Laboratories, Inc. /Old/
Auriga Laboratories, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Researches and develops pharmaceutical products | Health Technology |
Tacora Corp
 Tacora Corp Miscellaneous Commercial ServicesCommercial Services Develops bioresponsive smart polymers | Commercial Services |
The Rockefeller University
 The Rockefeller University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The GW Group | |
PharmaSpec Corp. | |
Ciba-Geigy Pharmaceuticals | |
Safety Shot, Inc.
 Safety Shot, Inc. Pharmaceuticals: OtherHealth Technology Manufactures photocil dietary supplement products | Health Technology |
Tapimmune, Inc. | |
Cadrenal Therapeutics, Inc.
 Cadrenal Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel therapy with orphan drug indication | Health Technology |
